- 2019. Blood metabolites associate with prognosis in endometrial cancer. Metabolites. 1-15.
- 2018. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer. Scientific Reports. 1-9.
- 2017. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. OncoTarget. 87837-87847.
- 2016. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy. Cancer Medicine. 1840-1849.
- 2018. Prognostic biomarkers in stage II and III colorectal cancer: A study with focus on microRNAs and S100A4.